Latin American health and pharma company Procaps Group (NASDAQ: PROC) was once again named as the most innovative company in the Colombian pharmaceutical segment by a joint ranking produced by the National Business Association of Colombia (ANDI) and Dinero magazine.
This is the fifth year in a row that Procaps has placed first in the group’s annual “innovation ranking,” which measures firms in Colombia on their innovation capacity in areas including organizational culture, product innovation, and marketing.
In a release recognizing the honor, Procaps noted that it has previously received other innovation kudos from the Colombian Ministry of Sciences, Technology, and Innovation, and was the first pharmaceutical company in Colombia to receive the certification of its innovation management system (through NTC-5801:2018, awarded by Icontec in 2022).
“We appreciate once again receiving recognition for our team’s innovative vision and accomplishments,” said Ruben Minski, CEO of Procaps Groups.
He added that “we have a direct presence and export to more than 50 countries worldwide, as well as over 40 granted patents on oral delivery system technologies and continuous development of new patents.”